Pfizer Inc. (ETR:PFE)

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of EUR 121.60 billion. The enterprise value is 164.20 billion.

Market Cap	121.60B
Enterprise Value	164.20B

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.27%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 13.25 and the forward PE ratio is 8.64.

PE Ratio	13.25
Forward PE	8.64
PS Ratio	2.23
PB Ratio	1.60
P/TBV Ratio	n/a
P/FCF Ratio	11.45
P/OCF Ratio	9.38
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.33, with an EV/FCF ratio of 15.47.

EV / Earnings	17.89
EV / Sales	2.97
EV / EBITDA	7.33
EV / EBIT	10.59
EV / FCF	15.47

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.70.

Current Ratio	1.16
Quick Ratio	0.78
Debt / Equity	0.70
Debt / EBITDA	2.42
Debt / FCF	4.99
Interest Coverage	6.26

Financial Efficiency

Return on equity (ROE) is 12.17% and return on invested capital (ROIC) is 7.18%.

Return on Equity (ROE)	12.17%
Return on Assets (ROA)	5.25%
Return on Invested Capital (ROIC)	7.18%
Return on Capital Employed (ROCE)	10.53%
Revenue Per Employee	672,611
Profits Per Employee	113,294
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.45

Taxes

Income Tax	-200.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.66% in the last 52 weeks. The beta is 0.47, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-18.66%
50-Day Moving Average	21.23
200-Day Moving Average	21.87
Relative Strength Index (RSI)	48.08
Average Volume (20 Days)	66,091

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.22

Income Statement

In the last 12 months, Pfizer had revenue of EUR 54.48 billion and earned 9.18 billion in profits. Earnings per share was 1.62.

Revenue	54.48B
Gross Profit	40.22B
Operating Income	15.14B
Pretax Income	8.99B
Net Income	9.18B
EBITDA	20.92B
EBIT	15.14B
Earnings Per Share (EPS)	1.62

Balance Sheet

The company has 11.31 billion in cash and 52.95 billion in debt, giving a net cash position of -41.65 billion.

Cash & Cash Equivalents	11.31B
Total Debt	52.95B
Net Cash	-41.65B
Net Cash Per Share	n/a
Equity (Book Value)	75.97B
Book Value Per Share	13.32
Working Capital	5.10B

Cash Flow

In the last 12 months, operating cash flow was 12.96 billion and capital expenditures -2.35 billion, giving a free cash flow of 10.62 billion.

Operating Cash Flow	12.96B
Capital Expenditures	-2.35B
Free Cash Flow	10.62B
FCF Per Share	n/a

Margins

Gross margin is 73.82%, with operating and profit margins of 27.78% and 16.84%.

Gross Margin	73.82%
Operating Margin	27.78%
Pretax Margin	16.50%
Profit Margin	16.84%
EBITDA Margin	38.39%
EBIT Margin	27.78%
FCF Margin	19.49%

Dividends & Yields

This stock pays an annual dividend of 1.55, which amounts to a dividend yield of 7.31%.

Dividend Per Share	1.55
Dividend Yield	7.31%
Dividend Growth (YoY)	0.21%
Years of Dividend Growth	1
Payout Ratio	95.83%
Buyback Yield	-0.92%
Shareholder Yield	6.35%
Earnings Yield	7.55%
FCF Yield	8.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	8